|
1
|
Chen Z, Jin Y, Yu D, Wang A, Mahjabeen I,
Wang C, Liu X and Zhou X: Down-regulation of the microRNA-99 family
members in head and neck squamous cell carcinoma. Oral Oncol.
48:686–691. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Borel C, Deutsch S, Letourneau A,
Migliavacca E, Montgomery SB, Dimas AS, Vejnar CE, Attar H,
Gagnebin M, Gehrig C, et al: Identification of cis- and
trans-regulatory variation modulating microRNA expression levels in
human fibroblasts. Genome Res. 21:68–73. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Macfarlane LA and Murphy PR: MicroRNA:
Biogenesis, function and role in cancer. Curr Genomics. 11:537–561.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Davidson B, Tropé CG and Reich R: The
clinical and diagnostic role of microRNAs in ovarian carcinoma.
Gynecol Oncol. 133:640–646. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nugent M: MicroRNA function and
dysregulation in bone tumors: The evidence to date. Cancer Manag
Res. 6:15–25. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li M, Tian L, Ren H, Chen X, Wang Y, Ge J,
Wu S, Sun Y, Liu M and Xiao H: MicroRNA-101 is a potential
prognostic indicator of laryngeal squamous cell carcinoma and
modulates CDK8. J Transl Med. 13:2712015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu JY, Lu JB and Xu Y: MicroRNA-153
inhibits the proliferation and invasion of human laryngeal squamous
cell carcinoma by targeting KLF5. Exp Ther Med. 11:2503–2508. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu S, Jia S and Xu P: MicroRNA-9 as a
novel prognostic biomarker in human laryngeal squamous cell
carcinoma. Int J Clin Exp Med. 7:5523–5528. 2014.PubMed/NCBI
|
|
11
|
Wu X, Cui CL, Chen WL, Fu ZY, Cui XY and
Gong X: miR-144 suppresses the growth and metastasis of laryngeal
squamous cell carcinoma by targeting IRS1. Am J Transl Res. 8:1–11.
2016.PubMed/NCBI
|
|
12
|
Yu WF, Wang HM, Lu BC, Zhang GZ, Ma HM and
Wu ZY: miR-206 inhibits human laryngeal squamous cell carcinoma
cell growth by regulation of cyclinD2. Eur Rev Med Pharmacol Sci.
19:2697–2702. 2015.PubMed/NCBI
|
|
13
|
Zhong G and Xiong X: miR-205 promotes
proliferation and invasion of laryngeal squamous cell carcinoma by
suppressing CDK2AP1 expression. Biol Res. 48:602015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu C, Guan H, Wang Y, Chen M, Xu B, Zhang
L, Lu K, Tao T, Zhang X and Huang Y: miR-195 inhibits EMT by
targeting FGF2 in prostate cancer cells. PLoS One. 10:e01440732015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Luo Q, Zhang Z, Dai Z, Basnet S, Li S, Xu
B and Ge H: Tumor-suppressive microRNA-195-5p regulates cell growth
and inhibits cell cycle by targeting cyclin dependent kinase 8 in
colon cancer. Am J Transl Res. 8:2088–2096. 2016.PubMed/NCBI
|
|
16
|
Singh R, Yadav V, Kumar S and Saini N:
MicroRNA-195 inhibits proliferation, invasion and metastasis in
breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1.
Sci Rep. 5:174542015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao C, Qi L, Chen M, Liu L, Yan W, Tong S
and Zu X: microRNA-195 inhibits cell proliferation in bladder
cancer via inhibition of cell division control protein 42
homolog/signal transducer and activator of transcription-3
signaling. Exp Ther Med. 10:1103–1108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo J, Wang M and Liu X: MicroRNA-195
suppresses tumor cell proliferation and metastasis by directly
targeting BCOX1 in prostate carcinoma. J Exp Clin Cancer Res.
34:912015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Baer C, Claus R and Plass C: Genome-wide
epigenetic regulation of miRNAs in cancer. Cancer Res. 73:473–477.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu B, Qu J, Xu F, Guo Y, Wang Y, Yu H and
Qian B: MiR-195 suppresses non-small cell lung cancer by targeting
CHEK1. Oncotarget. 6:9445–9456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tan YG, Zhang YF, Guo CJ, Yang M and Chen
MY: Screening of differentially expressed microRNA in ulcerative
colitis related colorectal cancer. Asian Pac J Trop Med. 6:972–976.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo J, Miao Y, Xiao B, Huan R, Jiang Z,
Meng D and Wang Y: Differential expression of microRNA species in
human gastric cancer versus non-tumorous tissues. J Gastroenterol
Hepatol. 24:652–657. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Sohn W, Kim J, Kang SH, Yang SR, Cho JY,
Cho HC, Shim SG and Paik YH: Serum exosomal microRNAs as novel
biomarkers for hepatocellular carcinoma. Exp Mol Med. 47:e1842015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu J, Ji A, Wang X, Zhu Y, Yu Y, Lin Y,
Liu Y, Li S, Liang Z, Xu X, et al: MicroRNA-195-5p, a new regulator
of Fra-1, suppresses the migration and invasion of prostate cancer
cells. J Transl Med. 13:2892015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu ZM, Lin YF, Jiang L, Chen LS, Luo XN,
Song XH, Chen SH and Zhang SY: Micro-ribonucleic acid expression
profiling and bioinformatic target gene analyses in laryngeal
carcinoma. Onco Targets Ther. 7:525–533. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu L, Chen L, Xu Y, Li R and Du X:
microRNA-195 promotes apoptosis and suppresses tumorigenicity of
human colorectal cancer cells. Biochem Biophys Res Commun.
400:236–240. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang L, Qian L, Li X and Yan J:
MicroRNA-195 inhibits colorectal cancer cell proliferation,
colony-formation and invasion through targeting CARMA3. Mol Med
Rep. 10:473–478. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo H, Li W, Zheng T and Liu Z: MiR-195
targets HDGF to inhibit proliferation and invasion of NSCLC cells.
Tumour Biol. 35:8861–8866. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Singh B, Gogineni SK, Sacks PG, Shaha AR,
Shah JP, Stoffel A and Rao PH: Molecular cytogenetic
characterization of head and neck squamous cell carcinoma and
refinement of 3q amplification. Cancer Res. 61:4506–4513.
2001.PubMed/NCBI
|
|
31
|
Huang G, Kaufman AJ, Ramanathan Y and
Singh B: SCCRO (DCUN1D1) promotes nuclear translocation and
assembly of the neddylation E3 complex. J Biol Chem.
286:10297–10304. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yoo J, Lee SH, Lym KI, Park SY, Yang SH,
Yoo CY, Jung JH, Kang SJ and Kang CS: Immunohistochemical
expression of DCUN1D1 in non-small cell lung carcinoma: Its
relation to brain metastasis. Cancer Res Treat. 44:57–62. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sarkaria I, O-charoenrat P, Talbot SG,
Reddy PG, Ngai I, Maghami E, Patel KN, Lee B, Yonekawa Y, Dudas M,
et al: Squamous cell carcinoma related oncogene/DCUN1D1 is highly
conserved and activated by amplification in squamous cell
carcinomas. Cancer Res. 66:9437–9444. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liotta LA, Steeg PS and Stetler-Stevenson
WG: Cancer metastasis and angiogenesis: An imbalance of positive
and negative regulation. Cell. 64:327–336. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Folkman J: What is the evidence that
tumors are angiogenesis dependent? J Natl Cancer Inst. 82:4–6.
1990. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
MacDougall JR and Matrisian LM:
Contributions of tumor and stromal matrix metalloproteinases to
tumor progression, invasion and metastasis. Cancer Metastasis Rev.
14:351–362. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
O-Charoenrat P, Rhys-Evans PH and Eccles
SA: Expression of matrix metalloproteinases and their inhibitors
correlates with invasion and metastasis in squamous cell carcinoma
of the head and neck. Arch Otolaryngol Head Neck Surg. 127:813–820.
2001.PubMed/NCBI
|
|
39
|
O-Charoenrat P, Sarkaria I, Talbot SG,
Reddy P, Dao S, Ngai I, Shaha A, Kraus D, Shah J, Rusch V, et al:
SCCRO (DCUN1D1) induces extracellular matrix invasion by activating
matrix metalloproteinase 2. Clin Cancer Res. 14:6780–6789. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Jiang Z, Song Q, Zeng R, Li J, Li J, Lin
X, Chen X, Zhang J and Zheng Y: MicroRNA-218 inhibits EMT,
migration and invasion by targeting SFMBT1 and DCUN1D1 in cervical
cancer. Oncotarget. 7:45622–45636. 2016. View Article : Google Scholar : PubMed/NCBI
|
